RCS-01
- Generic Name
- RCS-01
Study of Intradermal Injections of RCS-01 in Male and Female Subjects
Phase 1
Completed
- Conditions
- Intrinsic Aging of SkinSkin WrinklingSolar Degeneration of Skin
- Interventions
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- RepliCel Life Sciences, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT02391935
- Locations
- 🇩🇪
IUF Leibniz-Institut für umweltmedizinische Forschung gGmbH, Düsseldorf, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath